Continuous glucose monitoring and metrics for clinical trials

Association between continuous glucose monitoring metrics and ...

Diabetes Research and Clinical Practice 212 (2024) 111690. 2. An international consensus statement on the use of CGM metrics in clinical ...

Using continuous glucose monitoring data in daily clinical practice

More recent data suggest that extending the data collection period for CGM metrics beyond 14 days may decrease the impact of short-term ...

Use of Continuous Glucose Monitoring as an Outcome Measure in ...

CGM inaccuracy and underestimation of the extremes of hyperglycemia and hypoglycemia can be accounted for in a clinical trial's study design.

Clinical Targets for Continuous Glucose Monitoring Data Interpretation

As shown in studies, >70% use of CGM over the recent. 14 days correlates strongly with 3 months of mean glucose, time in ranges, and hyperglycemia metrics (41; ...

Continuous Glucose Monitoring Versus Usual Care in Patients With ...

To determine the effectiveness of CGM in adults with type 2 diabetes receiving multiple daily injections of insulin. Design: Randomized clinical trial. (The ...

aace guide to continuous glucose monitoring (cgm)

What are the indications for CGM in persons with diabetes mellitus? · In people with diabetes on MDI or CSII, rtCGM devices should be used as close to daily as ...

Relationship of continuous glucose monitoring-related metrics with ...

The targets for continuous glucose monitoring (CGM)-derived metrics were recently set; however, studies on CGM data over a long period with ...

Minimum Sampling Duration for Continuous Glucose Monitoring ...

Continuous Glucose Monitoring Metrics to ... International consensus of continuous glucose monitor use in pharmacological clinical trials in diabetes.

Importance of Continuous Glucose Monitoring-derived Metrics ...

Current guidelines recommend assessing glycemic control using continuous glucose monitoring (CGM) and hemoglobin A1c (HbA1c) measurement. Objective. This study ...

Continuous Glucose Monitoring Overview: Features and Evidence

A recent study in persons with T1D concluded that 14 days of CGM data correlates well with glucose metrics, including mean glucose, TIR, and ...

Minimum duration of continuous glucose monitoring data to estimate ...

An online tool to facilitate its implementation is made freely avail- able to the clinical investigator. KEYWORDS clinical trial, continuous ...

A Consensus Statement for Continuous Glucose Monitoring Metrics ...

Diabetes Technology Society organized an expert consensus panel to develop metrics for research in the use of continuous glucose monitors (CGMs) ...

Continuous Glucose Monitoring > Clinical Keywords > Yale Medicine

Continuous glucose monitoring (CGM) is a method used to track glucose levels in real-time throughout the day and night. It involves the use of a small ...

Use of CGM metrics more common in diabetes care, but still limited

People with diabetes using wearable CGM are able to share device-generated ambulatory glucose profiles with physicians and other care providers.

protocol for a systematic review and meta-analysis - BMJ Open

More comprehensive sampling as obtained with continuous glucose monitoring (CGM) may improve diagnostic accuracy of the transition from health to pre-diabetes.

Glucodensity Functional Profiles Outperform Traditional Continuous ...

Recently, there has been growing interest in utilizing CGM devices in clinical studies involving healthy and diabetes populations. However, ...

Effect of continuous glucose monitoring on glycemic control in ...

RESULTS: Among the 153 participants (mean [SD] age, 17 [3] years; 76 [50%] were female; mean [SD] diabetes duration, 9 [5] years), 142 (93%) completed the study ...

Recognized Consensus Standards: Medical Devices - FDA

This guideline provides recommendations for methods used to determine analytical and clinical metrics of continuous glucose monitoring (CGM) ...

Implantable Continuous Glucose Monitors (I-CGM) (L38664) - CMS

Among these 9 studies, the average MARD of I-CGM ranged between 8.8% to 12.3%.14-16, 18, 20-24. Clinical Efficacy. Glycated hemoglobin (HbA1c) is a key measure ...

Correct interpretation of key CGM metrics

Besides self-monitoring of blood glucose (SMBG) with a few glucose measurements per day, nowadays continuous glucose monitoring (CGM) is a ...